Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL

Jennifer Woyach, MD, Shanmugapriya Thangavadivel, PhD, David Weiss, Lai Wei, PhD, Eric McLaughlin, MS, Kerry Rogers, Seema A. Bhat, MD, Michael R. Grever, MD, Michael Keller, Matthew Dort, Gerard Lozanski, MD, Barbara Andersen, PhD, John C. Byrd, MD, Farrukh T. Awan, MD

Blood (2019) 134 (Supplement_1): 1759.

https://doi.org/10.1182/blood-2019-131099

Published: 2019

Journal Articles

Standard Definitions of Pneumococcal Immunity May Not Accurately Predict Protection in Adults with Sickle Cell Disease

Tara M. Robinson, MD PhD, Sophie M. Lanzkron, MD

Blood (2019) 134 (Supplement_1): 1014.

https://doi.org/10.1182/blood-2019-126056

Published: 2019

Journal Articles

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Gloria Contreras-Yametti, MD, Custodio Haidee, MD, Hamayun Imran, MD MSc

Blood (2018) 132 (Supplement 1): 3665.

https://doi.org/10.1182/blood-2018-99-111362

Published: 2018

Journal Articles

Spatial Distribution of Invasive Pneumococcal Serotypes in West Africa: A Retrospective Analysis to Inform Immunization in Persons with Sickle Cell Disease

Thomas Carsillo, PhD, Kokou Hefoume Amegan-Aho, MD, Andrea Feller, PhD, Avery McIntosh, PhD, Jonathan Spector, MD MPH, Stephen K. Obaro, MD PhD

Blood (2018) 132 (Supplement 1): 3668.

https://doi.org/10.1182/blood-2018-99-119406

Published: 2018

Journal Articles

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

Kirshma Khemani, MD, Molly K Steele, Nitya Bakshi, MBBS, MS, Lakshmanan Krishnamurti, MD, Inci Yildirim, MD PhD MSc FAAP

Blood (2018) 132 (Supplement 1): 3406.

https://doi.org/10.1182/blood-2018-99-119283

Published: 2018

Journal Articles

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Louise Smith, RCN MSc, Elizabeth Ryan, MB ChB, Russell D Keenan, MBChB, PhD FRCP, FRCPath, Rekha Thangavelu, MB ChB FRCP FRCPath

Blood (2018) 132 (Supplement 1): 4927.

https://doi.org/10.1182/blood-2018-99-119768

Published: 2018

Journal Articles

Pneumococcal Vaccination (PCV13) Prior to Initiation of Immunosuppressive Therapy in Patients with Hematological Malignancies Is Associated with Decrease Morbidity and Decrease Hospitalizations

Regina Draliuk, MA, Iveta Mintsman, MD, Alla Shnaider, Shuras Viky, Rotem Benami, Noga Salem, Olga Valkovsky, MD, Mouna Ballan Haj, MD, Evelyne Shabad, MD, Antonio Kotler, MD, Elena Mishchenko, MD, Meir Preis, MD PhD

Blood (2018) 132 (Supplement 1): 5919.

https://doi.org/10.1182/blood-2018-99-118483

Published: 2018

Journal Articles

Comparison of Response to Vaccination with PCV 13 in Patients with Multiple Myeloma Versus Healthy Controls

Deep Shah, Shahzad Mustafa, Jonathan Bress, Saad Jamshed, MD

Blood (2017) 130 (Supplement 1): 5418.

https://doi.org/10.1182/blood.V130.Suppl_1.5418.5418

Published: 2017

Journal Articles

A Phase 2 Study of Lenalidomide to Repair Immune Synapse Response and Humoral Immunity in Early-Stage, Asymptomatic Chronic Llmphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with High-Risk Genomic Features

Jeffrey A. Jones, MD MPH, Amy J. Johnson, PhD, Farrukh T. Awan, Quihong Zhao, MAS, Natarajan Muthusamy, DVM, PhD, Kami J. Maddocks, MD, Leslie A. Andritsos, MD, Kerry A. Rogers, MD, Jennifer A. Woyach, MD, Gerard Lozanski, MD, Nyla A. Heerema, PhD, Cathy Brookfield, BSN, Amy S Ruppert, MAS, John C. Byrd, MD

Blood (2016) 128 (22): 4388.

https://doi.org/10.1182/blood.V128.22.4388.4388

Published: 2016

Journal Articles

Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial)

Najibah Aliyu Galadanci, MBBS MPH, Shehu Umar Abdullahi, MBBS, Leah Danielle Vance, BS, Musa Tabari, MBBS, Shehi Abubakar, MBBS, Belonwu Raymond, MBBS, Salihu Auwal, MBBS, Aisha Amal Galadanci, MBBS, Binta WUDIL Jibir, MBBS MPH, Halima Bello-Manga, MBBS, MPH, Kathleen A Neville, MD MS, Fenella Kirkham, MD, Yu Shyr, MD, Sharon E. Phillips, MSPH, Brittany Covert, MPH, CCRP, Adetola A. Kassim, MD MS, Lori Jordan, MD, Muktar Aliyu, MD PhD, Michael DeBaun, MD

Blood (2016) 128 (22): 122.

https://doi.org/10.1182/blood.V128.22.122.122

Published: 2016

Journal Articles

Antibody Response to Pneumococcal Conjugate Vaccine (PCV13) in Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib

Benjamin Andrick, Pharm.D., Abulrahman Alwhaibi, Pharm.D., David DeRemer, Pharm.D., BCOP, FCCP, Sameera Quershi, BS, Rahil Khan, BS, MPH, Somanath Shenoy, PhD, FAHA, Jeremy M Pantin, MD

Blood (2016) 128 (22): 5597.

https://doi.org/10.1182/blood.V128.22.5597.5597

Published: 2016

Journal Articles

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

Michael A Thompson, MD PhD, Martin K Oaks, PhD, John O Richards, PhD, Maharaj Singh, PhD, Thomas S Smith, BS, Karen M Michel, BS, Andinet W Alemu, MD, Michael P. Mullane, MD, Husam S Tarawneh, MD, Angela M Kraut, Kayla J Hamm, Carla Fuentes

Blood (2016) 128 (22): 5607.

https://doi.org/10.1182/blood.V128.22.5607.5607

Published: 2016

Journal Articles

Improving Care of Patients with Sickle Cell Disease through Discrete Clinical Data Extraction and Automated Analysis of the Electronic Healthcare Records

E. Anders Kolb, MD, Erin Coyne, MSN, NP, Erin Crowgey, PhD, Villanueva Raymond, BSN, RN, CHTS-CP, Jean Wadman, MSN, NP, Sidnie Jacobs-Allen, Robin E. Miller, MD

Blood (2016) 128 (22): 2331.

https://doi.org/10.1182/blood.V128.22.2331.2331

Published: 2016

Journal Articles

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Patrick T. McGann, MD, Margarida Muhongo, Elizabeth McGann, Vysolela de Oliveira, Brigida Santos, MD, Russell E. Ware, MD, PhD

Blood (2013) 122 (21): 2934.

https://doi.org/10.1182/blood.V122.21.2934.2934

Published: 2013

Journal Articles

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

Mariane De Montalembert, MD, Miguel R. Abboud, MD, Anne Fiquet, MD, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, Normeen Kaddah, MD, Antonio Piga, MD, Baba Inusa, MD, Qin Jiang, MS, Lisa Pereira, BSc, Emilio A. Emini, PhD, William C. Gruber, MD, Alejandra Gurtman, MD, Daniel A. Scott, MD

Blood (2012) 120 (21): 3212.

https://doi.org/10.1182/blood.V120.21.3212.3212

Published: 2012

Journal Articles

A Prospective Pilot Newborn Screening and Treatment Program for Sickle Cell Anemia in the Republic of Angola

Patrick T. McGann, MD, Margaret G. Ferris, PhD, Paulino Macosso, Vysolela de Oliveira, Uma Ramamurthy, PhD, MBA, Ana Ruth Luis, MD, Luis Bernardino, MD, Russell E. Ware, MD, PhD

Blood (2012) 120 (21): 480.

https://doi.org/10.1182/blood.V120.21.480.480

Published: 2012

Journal Articles

Pneumococcal Bacteremia Among Patients with Hematological Malignancies: Clinical Impact, Serotype Distribution and Antibiotic Resistance Profile in Tertiary-Care Centers

Sophie Savary Bélanger, MD, Shi Hann Su, MD, FRCPC, Sylvie Bélanger, RN, Brigitte Lefebvre, PhD, Valéry Lavergne, MD, FRCPC, Sandra Cohen, MD, FRCPC, Annie-Claude Labbé, MD, FRCPC

Blood (2012) 120 (21): 2067.

https://doi.org/10.1182/blood.V120.21.2067.2067

Published: 2012

Journal Articles

Phase I Trial of Prophylactic Rituximab for the Prevention of Post Transplant Epstein-Barr Related Lymphoproliferative Disease (EBV-PTLD) Following T Cell Depleted (TCD) Unrelated or HLA-Mismatched Related Hematopoietic Cell Transplantation (HCT): Efficacy, Toxicity, and Effect on Subsequent B Cell Reconstitution

Trudy N Small, MD, Nancy A. Kernan, MD, Ann A. Jakubowski, MD, PhD, Molly A Knowles, BA, James W Young, MD, Hugo Castro-Malaspina, MD, Susan E Prockop, MD, Richard J. O'Reilly, MD, Esperanza B Papadopoulos, MD

Blood (2011) 118 (21): 1971.

https://doi.org/10.1182/blood.V118.21.1971.1971

Published: 2011

Journal Articles

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Trudy N Small, MD, Ann A. Jakubowski, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP, Nancy A. Kernan, MD, Susan E Prockop, MD, Christine Scura Iovino, APRN-BC, FNP-C, LeStrange Nicole, NP, Miguel-Angel Perales, MD, Hugo Castro-Malaspina, MD, Guenther Koehne, MD, PhD, Sergio Giralt, MD, Esperanza B Papadopoulos, MD

Blood (2011) 118 (21): 3037.

https://doi.org/10.1182/blood.V118.21.3037.3037

Published: 2011

NARROW

Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL

Standard Definitions of Pneumococcal Immunity May Not Accurately Predict Protection in Adults with Sickle Cell Disease

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Spatial Distribution of Invasive Pneumococcal Serotypes in West Africa: A Retrospective Analysis to Inform Immunization in Persons with Sickle Cell Disease

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Pneumococcal Vaccination (PCV13) Prior to Initiation of Immunosuppressive Therapy in Patients with Hematological Malignancies Is Associated with Decrease Morbidity and Decrease Hospitalizations

Comparison of Response to Vaccination with PCV 13 in Patients with Multiple Myeloma Versus Healthy Controls

A Phase 2 Study of Lenalidomide to Repair Immune Synapse Response and Humoral Immunity in Early-Stage, Asymptomatic Chronic Llmphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with High-Risk Genomic Features

Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial)

Antibody Response to Pneumococcal Conjugate Vaccine (PCV13) in Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

Improving Care of Patients with Sickle Cell Disease through Discrete Clinical Data Extraction and Automated Analysis of the Electronic Healthcare Records

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

A Prospective Pilot Newborn Screening and Treatment Program for Sickle Cell Anemia in the Republic of Angola

Pneumococcal Bacteremia Among Patients with Hematological Malignancies: Clinical Impact, Serotype Distribution and Antibiotic Resistance Profile in Tertiary-Care Centers

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only